Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Martin

Showing results (921-930 of 1,728) with videos related to

Pageof 173
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1993
Standard parameters of preeclampsia: can the clinician depend upon them to reliably identify the patient with the HELLP syndrome?E F Magann, S P Chauhan, R W Naef, et al.
AJNR. American Journal of Neuroradiology|May 1, 1994
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer diseaseS Lehéricy, M Baulac, J Chiras, et al.
Neuroradiology|April 1, 1994
Acute bilateral striatal necrosis in an infant: CT and MRIM T Sola Martínez, L Pierot, G Noseda, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 29, 2000
Cardiopulmonary morbidity as a complication of severe preeclampsia HELLP syndromeD A Terrone, C M Isler, W L May, et al.
Obstetrics and Gynecology|July 27, 2000
Detection of growth-restricted fetuses in preeclampsia: a case-control studyS P Chauhan, J A Scardo, E F Magann, et al.
American Journal of Obstetrics and Gynecology|June 16, 1999
Multiple courses of betamethasone to enhance fetal lung maturation do not suppress neonatal adrenal responseD A Terrone, B K Rinehart, P G Rhodes, et al.
American Journal of Obstetrics and Gynecology|June 16, 1999
Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidityJ N Martin, W L May, E F Magann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)J Jaubert, F Jaubert, N Martin, et al.
Journal of Neuro-Oncology|January 5, 2000
Treatment of meningeal gliomatosisP F Pradat, K Hoang-Xuan, P Cornu, et al.
Obstetrical & Gynecological Survey|April 30, 2003
Cesarean delivery for fetal distress: rate and risk factorsSuneet P Chauhan, Everett F Magann, John R Scott, et al.
Pageof 173

Showing results (921-930 of 1,728) with videos related to

Sort By:
Pageof 173
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1993
Standard parameters of preeclampsia: can the clinician depend upon them to reliably identify the patient with the HELLP syndrome?E F Magann, S P Chauhan, R W Naef, et al.
AJNR. American Journal of Neuroradiology|May 1, 1994
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer diseaseS Lehéricy, M Baulac, J Chiras, et al.
Neuroradiology|April 1, 1994
Acute bilateral striatal necrosis in an infant: CT and MRIM T Sola Martínez, L Pierot, G Noseda, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 29, 2000
Cardiopulmonary morbidity as a complication of severe preeclampsia HELLP syndromeD A Terrone, C M Isler, W L May, et al.
Obstetrics and Gynecology|July 27, 2000
Detection of growth-restricted fetuses in preeclampsia: a case-control studyS P Chauhan, J A Scardo, E F Magann, et al.
American Journal of Obstetrics and Gynecology|June 16, 1999
Multiple courses of betamethasone to enhance fetal lung maturation do not suppress neonatal adrenal responseD A Terrone, B K Rinehart, P G Rhodes, et al.
American Journal of Obstetrics and Gynecology|June 16, 1999
Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidityJ N Martin, W L May, E F Magann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)J Jaubert, F Jaubert, N Martin, et al.
Journal of Neuro-Oncology|January 5, 2000
Treatment of meningeal gliomatosisP F Pradat, K Hoang-Xuan, P Cornu, et al.
Obstetrical & Gynecological Survey|April 30, 2003
Cesarean delivery for fetal distress: rate and risk factorsSuneet P Chauhan, Everett F Magann, John R Scott, et al.
Pageof 173